It's much too reasonable for me. I'm in with a cost basis of 3.51. No way in the world would I keep this position if I didn't think it was going much higher than 30 in the next 18 months.
You care to explain why all the fund managers are still buying even though we're above our one year price Target.
Before the pandemic the M&A valuation on a sale was between 17 and 21 times EBIDA.